insulin degludec and liraglutide

CHEBI:CHEBI_751620

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1860172
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
marketing_category
BLA
active_ingredient_strength
3.6 mg/mL
nui
M0160181
pharm_class_epc
GLP-1 Receptor Agonist [EPC]
pharm_class
Glucagon-Like Peptide 1 [CS]
pharm_class_cs
Glucagon-Like Peptide 1 [CS]
active_ingredient_name
INSULIN DEGLUDEC
pharm_class_moa
Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
labeler_name
Novo Nordisk
manufacturer_name
Novo Nordisk
unii
839I73S42A
marketing_start_date
20161121
package_marketing_start_date
20161121
generic_name
insulin degludec and liraglutide
brand_name
Xultophy 100/3.6
brand_name_base
Xultophy 100/3.6
product_ndc
0169-2911
application_number
BLA208583
spl_id
d0211545-0939-4ff1-8de7-6ee89b6e633f
package_ndc
0169-2911-15
package_description
5 SYRINGE, PLASTIC in 1 CARTON (0169-2911-15) / 3 mL in 1 SYRINGE, PLASTIC
spl_set_id
21335fe4-d395-4501-ac2a-2f20d7520da9
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class